Wall Street was buoyed by investor optimism that the longest federal government shutdown in U.S. history could be nearing an ...

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the ...

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

AbbVie's Q3 2025 earnings are in. Skyrizi is on fire, neuroscience is booming, but Botox is a bust. Get the summary.

Cigna shows strong Q3 results, revenue growth, firm guidance, discounted valuation, with support from buybacks,FCF and ...

Fintel reports that on November 12, 2025, Bernstein maintained coverage of Cigna Group (NYSE:CI) with a Market Perform ...

Flaster stepped into her new role on November 1 after joining the company last year as chief medical officer of Cigna ...

Cigna Group CI-1.23%decrease; red down pointing triangle logged higher profit and revenue in the third quarter, but the company warned that profits for its pharmacy-benefits business will be squeezed ...

A little-known Cigna Group subsidiary that sells generic drugs charges prices that skew higher than many competing suppliers, ...

Cigna (CI) came out with quarterly earnings of $7.83 per share, beating the Zacks Consensus Estimate of $7.7 per share. This compares to earnings of $7.51 per share a year ago. These figures are ...